147 related articles for article (PubMed ID: 37301712)
1. Implementation of a Multidisciplinary Inflammatory Breast Cancer Program for Quality Improvement.
Hussain MM; Ashley G; Daniel S; Sachin J; Amy K; Doreen A; Sasha B; Roman S; Ko Un P
Clin Breast Cancer; 2023 Aug; 23(6):e354-e358. PubMed ID: 37301712
[TBL] [Abstract][Full Text] [Related]
2. Tailoring Treatment for Patients with Inflammatory Breast Cancer.
Newman AB; Lynce F
Curr Treat Options Oncol; 2023 Jun; 24(6):580-593. PubMed ID: 37043118
[TBL] [Abstract][Full Text] [Related]
3. Contemporary surgical management of inflammatory breast cancer: a narrative review.
Adesoye T; Irwin S; Sun SX; Lucci A; Teshome M
Chin Clin Oncol; 2021 Dec; 10(6):57. PubMed ID: 35016511
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for locoregional failure in patients with inflammatory breast cancer treated with trimodality therapy.
Saigal K; Hurley J; Takita C; Reis IM; Zhao W; Rodgers SE; Wright JL
Clin Breast Cancer; 2013 Oct; 13(5):335-43. PubMed ID: 23850216
[TBL] [Abstract][Full Text] [Related]
5. Immediate Reconstruction in Inflammatory Breast Cancer: Challenging Current Care.
Simpson AB; McCray D; Wengler C; Crowe JP; Djohan R; Tendulkar R; O'Rourke C; Grobmyer SR; Valente SA
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):642-648. PubMed ID: 27638670
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Radiation Therapy for Chemorefractory Localized Inflammatory Breast Cancer.
Rogé M; Kirova Y; Loap P; Amar S; Servagi S; Nebbache R; Rivin Del Campo E; Clatot F; Thureau S; Thariat J
Pract Radiat Oncol; 2023; 13(6):e491-e498. PubMed ID: 37295726
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of breast-conserving therapy in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy.
Bonev V; Evangelista M; Chen JH; Su MY; Lane K; Mehta R; Butler J; Hsiang D
Am Surg; 2014 Oct; 80(10):940-3. PubMed ID: 25264634
[TBL] [Abstract][Full Text] [Related]
8. Current Surgical Management of Inflammatory Breast Cancer.
Adesoye T; Lucci A
Ann Surg Oncol; 2021 Oct; 28(10):5461-5467. PubMed ID: 34346020
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory Breast Cancer: Is There a Role for Deescalation of Surgery?
Nakhlis F
Ann Surg Oncol; 2022 Oct; 29(10):6106-6113. PubMed ID: 35840847
[TBL] [Abstract][Full Text] [Related]
10. Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experience.
Nakhlis F; Regan MM; Chun YS; Dominici LS; Caterson S; Bellon JR; Warren L; Yeh ED; Jacene HA; King TA; Overmoyer B
Breast J; 2020 Mar; 26(3):384-390. PubMed ID: 31448540
[TBL] [Abstract][Full Text] [Related]
11. Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy.
Tsai CJ; Li J; Gonzalez-Angulo AM; Allen PK; Woodward WA; Ueno NT; Lucci A; Krishnamurthy S; Gong Y; Yang W; Cristofanilli M; Valero V; Buchholz TA
Am J Clin Oncol; 2015 Jun; 38(3):242-7. PubMed ID: 23648437
[TBL] [Abstract][Full Text] [Related]
12. Update on systemic treatment for newly diagnosed inflammatory breast cancer.
Chainitikun S; Saleem S; Lim B; Valero V; Ueno NT
J Adv Res; 2021 Mar; 29():1-12. PubMed ID: 33842000
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory breast cancer: what we know and what we need to learn.
Yamauchi H; Woodward WA; Valero V; Alvarez RH; Lucci A; Buchholz TA; Iwamoto T; Krishnamurthy S; Yang W; Reuben JM; Hortobágyi GN; Ueno NT
Oncologist; 2012; 17(7):891-9. PubMed ID: 22584436
[TBL] [Abstract][Full Text] [Related]
14. Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery.
Rosso KJ; Tadros AB; Weiss A; Warneke CL; DeSnyder S; Kuerer H; Ueno NT; Stecklein SR; Woodward WA; Lucci A
Ann Surg Oncol; 2017 Oct; 24(10):2981-2988. PubMed ID: 28766220
[TBL] [Abstract][Full Text] [Related]
15. What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approach.
Yeh ED; Jacene HA; Bellon JR; Nakhlis F; Birdwell RL; Georgian-Smith D; Giess CS; Hirshfield-Bartek J; Overmoyer B; Van den Abbeele AD
Radiographics; 2013; 33(7):2003-17. PubMed ID: 24224593
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.
Nakhlis F; Regan MM; Warren LE; Bellon JR; Hirshfield-Bartek J; Duggan MM; Dominici LS; Golshan M; Jacene HA; Yeh ED; Mullaney EE; Overmoyer B
Ann Surg Oncol; 2017 Sep; 24(9):2563-2569. PubMed ID: 28560598
[TBL] [Abstract][Full Text] [Related]
17. Once-daily radiation therapy for inflammatory breast cancer.
Brown L; Harmsen W; Blanchard M; Goetz M; Jakub J; Mutter R; Petersen I; Rooney J; Stauder M; Yan E; Laack N
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):997-1003. PubMed ID: 24721591
[TBL] [Abstract][Full Text] [Related]
18. Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
Hieken TJ; Murphy BL; Boughey JC; Degnim AC; Glazebrook KN; Hoskin TL
Clin Breast Cancer; 2018 Aug; 18(4):e501-e506. PubMed ID: 29089281
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of curative-intent multimodal management of chemorefractory nonmetastatic inflammatory breast cancer.
Loap P; Nicaise B; Laki F; Loirat D; Pierga JY; Fourquet A; Kirova Y
Strahlenther Onkol; 2023 Jan; 199(1):30-37. PubMed ID: 35648170
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory breast cancer: a single centre analysis.
Gogia A; Raina V; Deo SV; Shukla NK; Mohanti BK; Sharma DN
Asian Pac J Cancer Prev; 2014; 15(7):3207-10. PubMed ID: 24815472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
